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The Efficacy of a Topical Homoeopathic Complex in Hydrogel (Apis mellifica 
6cH, Atropa belladonna 6cH, Hepar sulphuris calcareum 6cH, Magnetis polus 
australis 30cH and Silicea 6cH) on Stage One Onychocryptosis of the Hallux 
1. Introduction 
Onychocryptosis is a painful condition of the toe occurring principally in the hallux. It is 
characterised by the nail plate growing and digging into the nail fold causing pain, swelling, 
redness and possibly infections (Johnston, 2010). The pain associated with onychocryptosis is 
often severe enough to cause difficulty in walking, as a quarter of the body’s weight gets placed 
on the hallux joint (Martin et al., 2001). It is the most frequent foot problem encountered in clinical 
practice (Rehbock, 2009). Although, there are no statistics on the number of people suffering from 
onychocryptosis in South Africa up to date, according to the World Health Organization, 7.1 
million of people suffer from onychocryptosis in America alone (Rightdiagnosis, 2015). It is 
estimated that approximately 20% of patients presenting to doctors with a foot problem have 
onychocryptosis (Khan et al., 2014). The condition mainly affects young adolescents and adults 
(Karaca & Dereli, 2012). 
 
Most treatment for onychocryptosis is rendered by podiatrists and includes either non-surgical or 
surgical approaches. The procedures can be quite painful, invasive and costly, and some current 
conventional treatment methods are not always satisfactory as the condition reoccurs (Abby et al., 
2002).  
 
The following homoeopathic remedies Apis mellifica, Atopa belladona, Hepar sulphuris 
calcareum, Magnetis polus australis and Silicea are all indicated for symptoms associated with 
onychocryptosis (Vermeulen, 2011). Previous studies show that Magnetis polus australis 30cH 
and 1M used orally had some success in treating onychocryptosis (Rohl, 2008; Khan, 2012). 
Anecdotal evidence suggests that patients often apply their homoeopathic remedy topically and 
claim that it is effective; and Rohl (2008) recommended that research be conducted using the 
homoeopathic remedies as topical applications. However, there is no research to date to establish 
their effectiveness when used as a topical complex remedy on onychocryptosis. 
2. Aim of the study 
The aim of this study was to determine the efficacy of a topical homoeopathic complex hydrogel 
(Apis mellifica 6cH, Atropa belladona 6cH, Hepar sulphuris calcareum 6cH, Magnetis polus 
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australis 30cH and Silicea 6cH) on stage one onychocryptosis of the hallux, and a Likert scale was 




Onychocryptosis can occur on any toe, at the tips or either side, but the most common site is the 
hallux (big toe) (Karaca & Dereli, 2012). Initially it causes little inconvenience. However, as the 
nail grows, the ingrowing nail further penetrates into the surrounding soft tissues and sets up an 
acute inflammation. The skin becomes red, shiny and tense, and the toe appears swollen. There is 
throbbing pain, tenderness to the slightest pressure and a degree of localised swelling. The 
continued penetration of the nail spike prevents normal healing because of hypertrophy (the 
formation of excessive tissue) of the wound in the sulcus. This overlaps the nail plate, sometimes 
to a considerable extent, partially obscuring it. The affected area may provide an opportunity for 
the bacteria to invade and thus become infected.  Pus may exude from the point of penetration in 
the sulcus and be seen as a pocket lying beneath the sulcus epidermis or beneath the nail plate 
(Frowen et al., 2010). 
 
4. Diagnosis and investigation 
Diagnosis of onychocryptosis is based on medical history and physical examination. On medical 
history, the onset of the symptoms and aetiology is established. The physical examination consists 
of assessing the nail structure, shape, colour changes, signs of swelling, localized sweating and the 
length or position of the toes which may give clues to local nail abnormalities. The diagnosis is 
usually seen easily on physical examination (Yates, 2012). If a causal agent is suspected, other 
special investigation such as fungal cultures may be performed (Williams, 2016). 
 
5. Stages of onychocryptosis 
A staging system has been developed to grade the severity of onychocryptosis (Karaca & Dereli, 
2012). These stages are briefly reviewed below: 
 Stage one is characterized by swelling, erythema at the edge of the nail and pain on applying 
pressure over the nail fold (Isik et al., 2013).  
 Stage two is marked by symptoms of stage one along with increased swelling, seropurulent 
secretion, infection and ulceration on the nail fold (Isik et al., 2013).  
 Stage three is characterised by chronic inflammation, granulation and hypertrophy of the nail 
fold. In this stage all signs and symptoms are amplified (Karaca & Dereli, 2012). 
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6. METHODOLOGY 
 6.1 Research sample 
The research sample comprised 30 participants, male and female, aged between 18 to 40 years old, 
and presenting with stage one onychocryptosis. Participants were recruited by means of 
advertisement (Appendix A) placed at the University of Johannesburg with relevant permission 
granted.  
Participants were included in the study if they: 
 were between the ages of 18 and 40; and 
 Suffered from uncomplicated or stage one onychocryptosis of the hallux, in either acute or 
chronic form, with redness, pain and swelling as symptoms. 
 
Participants were excluded from the study if they: 
 Suffered from diabetes mellitus; 
 Presented with immune system deficiencies such as HIV and AIDS; 
 Suffered from severe chronic diseases such as rheumatoid arthritis, vascular disease and 
malignancy; 
 Suffered from stage two or three onychocryptosis that needs a surgical intervention; or 
 Were taking allopathic or alternative treatment for their onychocryptosis of the hallux during 
the study period.  
 
6.2 Research design and procedure  
This study was a randomised, double-blind, placebo-controlled study and was conducted at the 
Podiatric clinic of the University of Johannesburg (Appendix B) for a period of thirty days and 
included three appointments. On the first day of the study the potential participants were requested 
to read a Participant Information Form (Appendix C) and sign a Consent Form (Appendix D).  The 
researcher screened the participants using a questionnaire (Appendix E) to evaluate their suitability 
for the study and a podiatrist confirmed their stage of onychocryptosis. For selected participants, 
the researcher examined the participant’s onychocryptosis under the supervision of a podiatrist. 
The physical examination entailed assessing the degree of oedema, erythema and applying a 
moderate amount of pressure to the affected area/s. The researcher wore gloves at all times. When 
the participant expressed that the affected area/s was too painful to have pressure applied, he/she 
would instruct the researcher to not complete this action. The researcher then rated the participant’s 
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response to pressure, the degree of erythema and oedema using a Researcher Assessment Form 
(Appendix F). This rating was not conveyed to the participants. Participants then independently 
completed an Assessment Questionnaire (Appendix G) to rate the severity of their symptoms. 
Follow-up sessions took place on day fifteen and on day thirty of the study where the researcher 
physically examined the participant’s onychocryptosis together with a podiatrist and completed 
the Researcher Assessment Form (Appendix F). As in the first consultation, participants once 
again independently completed an Assessment Questionnaire (Appendix H) to rate the severity of 
their symptoms. 
 
6.3 Randomisation procedure 
The control and the experimental hydrogels were randomised and numbered by an independent 
registered homoeopathic pharmaceutical company ensuring that the researcher remained blind to 
which groups received which container of the hydrogel. Selected participants placed themselves 
into either the experimental or the control group by selecting a numbered hydrogel container. The 
number on the hydrogel was recorded as the participant’s number. 
 
6.4 Medication administration 
The control and the experimental hydrogels were made identical in colour, smell, and labelled in 
the same manner by a registered homoeopathic pharmaceutical company. The experimental 
hydrogels contained Apis mellifica 6cH, Atropa belladona 6cH, Hepar sulphuris calcareum 6cH, 
Magnetis polus australis 30cH and Silicea 6cH, and the control consisted of unmedicated 
hydrogels. Participants were given a 50 ml jar of hydrogel that they were instructed to apply on 
the clean and dry affected area/s in the morning and evening for a period of thirty days. 
6.5 Reliability and validity measures 
The homoeopathic complex hydrogels were manufactured by a registered homoeopathic 
pharmaceutical company using good manufacturing practices. A Likert scale from 1 to 4 was used 
to rate the symptoms of stage one onychocryptosis namely: pain, erythema and oedema. The Likert 
scale is a widely used and recognised assessment tool for measuring variables in research 
(McLeod, 2008).  Hasson & Arnetz (2005) conclude that the Likert scale is easy to use and is 
understandable for both the researcher and the participant. 
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6.6 Data collection and analysis 
At the end of the research period all data from the questionnaires was collected and statistically 
analysed with the assistance of a statistician at Statkon, UJ. The between-groups comparison was 
done using the Mann-Whitney U test. Comparison within the groups was done using the Friedman 
test and differences over the three period of time were done using the Wilcoxon post hoc test 
(Kuhudzai, 2015). 
 
7.  Interpretation of Findings 
The study involved the use of a combination homoeopathic remedy referred to as “complex 
prescribing”, which is the combination of two or more remedies based on their clinical indications 
into one vehicle (Sharma, 2011). Complexes are aimed at providing the patient with a number of 
medicinally active remedies which elicit particular effects for specific conditions (Kayne & Kayne 
2007). The advantage of complexes is that a particular symptom can be targeted using numerous 
ingredients known to address the symptoms producing a wider spectrum, or amplified action 
(Sharma, 2011).  
 
The remedies combined in the hydrogel base were selected based on their indications for 
onychocryptosis or other similar symptom pictures. It was confirmed that no remedies were known 
to antidote each other by reference in multiple homoeopathic materia medicas. Most of the 
remedies in the complex were in a 6cH potency which is the recommended potency prescribed in 
physical complaints (De Schepper, 2010), except for Magnetis polus australis which was in a 
30cH potency. Previous studies showed that Magnetis polus australis 30cH had some success in 
treating onychroptosis (Rohl, 2008). Anecdotal evidence suggests that patients often apply their 
homoeopathic remedy topically and claim that is effective. The positive results obtained from the 
study could be attributed to the topical application of the hydrogel on the affected area/s and the 
complex remedy. 
In placebo-controlled studies such as this one, the drug must perform significantly better than the 
placebo for it to prove effectiveness. A placebo is an inactive medicinal preparation having no 
specific pharmacological activity against the patient’s illness or complaint given solely for the 
psycho-physiological effects of the treatment (Jayasuriya, 2010). Placebos are commonly used in 
clinical trials as an inactive control so that researchers can better evaluate the true overall effect of 
the experimental drug treatment under study (Anderson, 2013).  
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The mean values of both subjective and objective measurements showed a greater improvement 
of symptoms in the treatment group than the placebo group.  
 
According to the participant’s own perception regarding their condition, when comparing the 
treatment and the placebo group demonstrated the Mann Whitney U test: 
 A statistically significant difference between the two groups in the reduction of pain in the 
hallux without applying pressure on the medial side of the left foot on day 30; 
 A statistically significant difference between the two groups in the reduction of tenderness 
to pressure on the hallux on medial side of the foot on day 30 and on the lateral side of the 
right foot on day 1; 
 A statistically significant difference between the two groups in the reduction of swelling on 
both sides of the left foot and on the medial side of the right foot on day 30; and 
 No statistically significant difference between the two groups in the reduction of redness on 
both left and right foot.  
 
The data obtained during physical examination when comparing the two groups, treatment and 
placebo revealed:  
 A statistically significant difference between the two groups, in the reduction of pain on 
palpation, on both sides of the left foot and on the medial side of the right foot on day 30; 
 A statistically significant difference between the two groups, in the reduction of oedema, 
on the medial side of both left and right foot on day 15 and day 30; and 
 No statistically significant difference between the two groups, in the reduction of redness 
on both left and right foot.  
 
Therefore, on both subjective and objective measurement, the treatment outperformed the placebo 
by relieving the symptoms of onychocryptosis mainly; pain in the hallux without applying any 
pressure, tenderness to pressure on the hallux (pain on palpation) and swelling (oedema) of the 
hallux. The improvement between the two groups was mostly observed at the end of the study. 
The medial side of the hallux showed a greater improvement than the lateral. This could be due 
to pressure of the shoes being relieved on the medial side hence accelerating the healing process. 
Participants with onychocryptosis on the left foot showed a greater improvement than those with 
the condition on the right foot. Scientists demonstrate that most of the people are not only right-
handed but also right-legged. A research conducted by Tavakkoli and Jose (2013) demonstrated 
that the right leg is more muscular and makes longer steps in walking. They noted that most people 
kick the ball with the right leg and if falling forward they catch themselves more often with the 
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right leg. This could be a reason why the right foot did not show a better improvement than the 
left foot due to the fact that quarter of the body’s weight gets placed on the right hallux.  
 
However, there was no statistically significant difference between the two groups, for both 
subjective and objective measurements in reducing redness associated with onychocryptosis. 
During a wound healing process there is increase of blood flow to the damaged area and formation 
of new blood vessels which cause the red discoloration of the skin. The process may take a bit 
longer depending on the severity of the damaged area (Thompson, 2016). The study was however 
too short to determine when exactly the healing process will end.     
 
Although this was a double blind study, the positive results obtained from the placebo, mostly in 
the Friedman test on tenderness to pressure on the lateral side of the left foot, could have been due 
to the placebo effect or the component of the hydrogel.  Hydrogel is a group of polymeric material 
which contain 90% of water in a gel base, which helps regulate fluid exchange from the wound 
surface. The cool sensation provided by the hydrogel to the wound offers relief from pain and 
simplify the healing phases such as epidermis repair (Ahmed, 2015). 
 
Other factors that might have caused positive results include: 
 The desire of the participants to please the researcher; 
 Spontaneous improvement; and 
 Fluctuation of the symptoms 
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